Search Results
54 items found for "European Medicines Agency"
- Ep 100 with Dr Caron Tribute Part 1
He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Ep 92 with Dr. Stephane Angers
antibody molecules blocking and activating the Wnt pathway for the treatment of cancers and regenerative medicine
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at
- Illuminating Functional Selectivity and Allosterism at GPCRs.
Stéphane Laporte is a Professor of Medicine, and the Director of Research of the Division of Endocrinology
- Ep 70 with Dr. Stephen Ferguson
Stephen Ferguson is a Professor in the Department of Cellular and Molecular Medicine at the University
- Ep 27 with Dr. Robert J. Lefkowitz
Duke Professor of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University Medical Center. He began his career in the late 1960s and has been an Investigator of the Howard Hughes Medical Institute
- Ep 102 with Dr Caron Tribute Part 3
He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Ep 53 with Dr. Timo De Groof
From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam Timo De Groof on the web LinkedIn Researchgate Twitter Medical Imaging Group Google Scholar Dr.
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
He is a Professor in the Departments of Medicine, Immunology and Medical Biophysics at the University After completing his medical studies at George Washington University, the NIH and UCLA, he pursued his
- The landscape of cancer-rewired GPCR signaling axes
Tags GPCR , cancer , cancer cell lines , cell-cell communication , drug repurposing , personalized medicine
- Ep 130 with Dr. Richard Premont
Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine
- Ep 131 with Dr. Richard Premont
Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine
- Ep 133 with Dr. Richard Premont
Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine
- Ep 132 with Dr. Richard Premont
Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
; Hattori, Takamitsu; Koide, Shohei; Placantonakis, Dimitris New York University Grossman School of Medicine Dimitris Placantonakis "Dimitris Placantonakis is a neurosurgeon-scientist at NYU Grossman School of Medicine Javitch in the Department of Psychiatry at Columbia University Irving Medical Center."
- Ep 152 with Dr Arthur Christopoulos
computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as the potential of certain drugs, like flumazenil, as 'nails' or compounds that could be developed into medicines
- Registration (private) | Dr. GPCR Ecosystem
see confirmation email for details *Cancel anytime *Free membership excludes personnel from US gov. agency
- GPCR Retreat 2023 - Part II
Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at
- GPCR Courses
Why are personnel from US governmental agencies excluded from the free membership? documentation during the sign-up process to confirm whether the individual is employed by a US governmental agency
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Tobias; Scholz, Nicole Rudolf Schönheimer Institute of Biochemistry, Divison of General Biochemistry, Medical Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC
- Ep 148 with Dr Arthur Christopoulos
computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as
- Ep 71 with Dr. Jean Martin Beaulieu
signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical agents
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Tara L Lin , Sandra L Silberman , Eunice S Wang , Amer M Zeidan Tags AML , Biomarker , Hypomethylating agents
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Jonathan A. (2), Mathiasen, Signe (1) (1) Department of Biomedical Sciences, Faculty of Health and Medical her dual-title PhD in Neuroscience and Clinical and Translational Sciences at Penn State College of Medicine
- Terms and Conditions | Dr. GPCR Ecosystem
applicable law, Ecosystem.DrGPCR.com (including our parent, subsidiaries, affiliates, officers, directors, agents INDEMNIFICATION: Customer agrees to indemnify, defend and hold Ecosystem.DrGPCR.com and its partners, agents
- Trademark Policy | Dr. GPCR Ecosystem
Neither party shall be deemed to be an employee, agent, partner, or legal representative of the other